All In Biotech

Free tool

FAERS Monitor: Quviviq

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214985 or its brand name (Quviviq, Daridorexant Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,777

Serious

996

36% of reports

Hospitalization

335

Death reported

78

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective482
  • insomnia327
  • nightmare281
  • somnolence183
  • fatigue171
  • headache168
  • product availability issue148
  • abnormal dreams137
  • feeling abnormal124
  • inappropriate schedule of product administration122
  • suicidal ideation100
  • dizziness98
  • nausea98
  • wrong technique in product usage process91
  • therapeutic product effect incomplete83

Reports by year received

View as table
YearReports
20201
20211
2022505
20231,154
2024217
2025402
2026497

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,382 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
nightmareSignal28162.055.516,696
product availability issueSignal14849.542.36,954
abnormal dreamsSignal13737.832.14,848
insomniaSignal3279.38.42,445
therapeutic product effect incompleteSignal838.87.2571
suicidal ideationSignal1008.36.8635
somnolenceSignal1836.96.0923
inappropriate schedule of product administrationSignal1225.14.3405
feeling abnormalSignal1243.93.3270
wrong technique in product usage processSignal913.42.8153
drug ineffectiveSignal4822.82.6580
headacheSignal1682.01.889
fatigue1711.71.446
dizziness981.51.216
nausea980.90.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.